Skip to main content

2 Result(s)

within Article Remove this filter Michael H. Woo Remove this filter Cancer Research Remove this filter

and

  1. No Access

    Article

    Enhanced antitumor activity of irofulven in combination with irinotecan in pediatric solid tumor xenograft models

    Irofulven, a novel chemotherapeutic agent with a broad spectrum of activity, is effective against preclinical models of pediatric tumors. The cytotoxic activity of irofulven is augmented when combined with age...

    Michael H. Woo, Jennifer K. Peterson… in Cancer Chemotherapy and Pharmacology (2005)

  2. No Access

    Article

    Pharmacokinetics of paclitaxel in an anephric patient

    Purpose: To assess the pharmacokinetics of paclitaxel for recurrent Wilms' tumor in an anephric pediatric patient receiving hemodialysis. Methods: Paclitaxel was administered at a dose of 250 mg/m2 and 350 mg/m2

    Michael H. Woo, David Gregornik… in Cancer Chemotherapy and Pharmacology (1999)